Romosozumab outperforms teriparatide and denosumab in bone strength
Published: | Updated:
Recent work presented at the 2025 annual meeting of American Society of Bone & Mineral Research found that romosozumab significantly outperformed teriparatide and denosumab in improving hip and spine bone strength.
